A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)

PHASE3CompletedINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

January 1, 2004

Primary Completion Date

July 1, 2005

Study Completion Date

July 25, 2005

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG

MK0906, finasteride / Duration of Treatment: 48 weeks

DRUG

Comparator: placebo / Duration of Treatment: 48 weeks

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00127179 - A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140) | Biotech Hunter | Biotech Hunter